Shevanthi Nayagam
- Epidemiology top 2%
- Hepatology top 0.5%
- Oncology top 10%
- Infectious Diseases top 5%
- Surgery
- Co-authors
- Mark ThurszTimothy B. HallettMaud LemoineGraham CookeElisa SicuriLesong ContehYusuke ShimakawaStefan Z. Wiktor
- Topics
- Hepatitis B Virus Studies (25 papers)Hepatitis C virus research (20 papers)Liver Disease Diagnosis and Treatment (14 papers)
- Partner nations
- United KingdomFranceGambia
In The Last Decade
Shevanthi Nayagam
37 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 102
- Epidemiology 1.2k
- Hepatology 1.0k
- Oncology 320
- Infectious Diseases 272
- Surgery 233
Countries citing papers authored by Shevanthi Nayagam
This map shows the geographic impact of Shevanthi Nayagam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shevanthi Nayagam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shevanthi Nayagam more than expected).
Fields of papers citing papers by Shevanthi Nayagam
This network shows the impact of papers produced by Shevanthi Nayagam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shevanthi Nayagam. The network helps show where Shevanthi Nayagam may publish in the future.
Co-authorship network of co-authors of Shevanthi Nayagam
This figure shows the co-authorship network connecting the top 25 collaborators of Shevanthi Nayagam. A scholar is included among the top collaborators of Shevanthi Nayagam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shevanthi Nayagam. Shevanthi Nayagam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 16 | |
| 7 | 15 | |
| 8 | 5 | |
| 9 | 14 | |
| 10 | 5 | |
| 11 | 26 | |
| 12 | 10 | |
| 13 | 7 | |
| 14 | 130 | |
| 15 | 12 | |
| 16 | 78 | |
| 17 | 261 | |
| 18 | 256 | |
| 19 | 189 | |
| 20 | 1 |
About Shevanthi Nayagam
Shevanthi Nayagam is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (25 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (14 papers). The work is most often cited by research in Hepatology (1.0k citations), Epidemiology (1.2k citations) and Infectious Diseases (272 citations). Shevanthi Nayagam has collaborated with scholars based in United Kingdom, France and Gambia. Frequent co-authors include Mark Thursz, Timothy B. Hallett, Maud Lemoine, Graham Cooke, Elisa Sicuri, Lesong Conteh, Yusuke Shimakawa, Stefan Z. Wiktor, Daniel Low‐Beer and Mark McPhail. Their work appears in journals such as The Lancet, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.